Skip to main content

Advertisement

Contact Claudia Arce

From: Adriamycin-Cyclophosphamide (AC) followed by Paclitaxel-Cisplatin (PC). A highly active neoadjuvant regimen in locally advanced breast cancer

Contact corresponding author